Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome

scientific article published on 27 March 2017

Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/00365521.2017.1305123
P698PubMed publication ID28346031

P50authorOdd Helge GiljaQ56655099
Trygve HauskenQ64051500
Jan Gunnar HatlebakkQ64140834
Magdy El-SalhyQ87422049
P2093author name stringTanisa Patcharatrakul
Sutep Gonlachanvit
P2860cites workIs chromogranin a prohormone?Q58966885
Neuropeptides and inflammatory bowel diseaseQ39940321
The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factorsQ41027346
Chromogranin A cell density as a diagnostic marker for lymphocytic colitisQ42350284
Prevalence of irritable bowel syndrome in Hong KongQ43359175
Functional bowel symptoms in a general Dutch population and associations with common stimulantsQ43662427
Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteriaQ43763654
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general populationQ44037464
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaireQ44056837
Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behaviorQ44592732
Monocyte migration: a novel effect and signaling pathways of catestatinQ46138950
Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whitesQ47188088
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.Q50995784
Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.Q51803884
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?Q51971888
The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD)Q26782555
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviourQ27002574
The chromogranin-secretogranin familyQ28185052
Functional bowel disordersQ29620328
Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndromeQ33852241
Are rice and spicy diet good for functional gastrointestinal disorders?Q33890531
The Current Prevalence of Irritable Bowel Syndrome in AsiaQ34298271
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impactQ34353536
Prevalence and management of abdominal cramping and pain: a multinational surveyQ34547643
Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowedQ34612294
Guidelines on the irritable bowel syndrome: mechanisms and practical management.Q34626602
Recent developments in the pathophysiology of irritable bowel syndromeQ35689193
The gut microbiota and irritable bowel syndrome: friend or foe?Q35942511
Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?Q36139386
High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitisQ36395349
Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor markerQ37779812
Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?Q37976162
Irritable bowel syndrome: the role of gut neuroendocrine peptidesQ38015086
High resolution colonic manometry--what have we learnt?--A review of the literature 2012.Q38109566
Is irritable bowel syndrome an organic disorder?Q38191561
Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatmentQ38192048
The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndromeQ39031805
A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster samplingQ39685480
Epidemiological features of irritable bowel syndrome in a Turkish urban societyQ39688027
A population-based study of irritable bowel syndrome in a non-Western populationQ39847065
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 4.0 InternationalQ24082749
P6216copyright statuscopyrightedQ50423863
P433issue6-7
P304page(s)691-697
P577publication date2017-03-27
P1433published inScandinavian Journal of GastroenterologyQ7429960
P1476titleChromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome
P478volume52

Reverse relations

cites work (P2860)
Q99567385Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome
Q92503461Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
Q48156442Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome
Q57291642Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms
Q91963317Nutritional Management of Gastrointestinal Diseases and Disorders
Q92628470Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
Q92053503Second Asian Consensus on Irritable Bowel Syndrome